Hemp Politics

Update: Lawmakers failed to take action on SB 255 during the 2017 legislative session, instead moving forward with a far more limited CBD-exemption bill.

A Senate lawmaker has reintroduced legislation, SB 255, to regulate marijuana access to qualified patients.

The measure, sponsored by Democrat Sen. Karen Tallian, establishes a statewide medical marijuana program to permit qualified patients — including patients with arthritis, migraine, PTSD, and seizures — to legally obtain cannabis products and to engage in cannabis therapy.

Twenty-nine states and the District of Columbia have enacted statewide provisions allowing patients access to cannabis therapy. Indiana patients deserve these same protections.

For more information, please contact Indiana NORML here or visit their Facebook page here.

Additional information regarding statewide efforts to legalize medical marijuana in Indiana is available from Hoosier Veterans for Medical Cannabis, which may be contacted via Facebook here. On Sunday, January 15, the American Legion of Indiana passed a resolution calling on state lawmakers to provide medical marijuana access.

Please enter your information below to contact your state Senator and urge them to support this pending legislation.

Update: The Missouri legislature is adjourned and the bill will not recieve further consideration this year.
Update: A hearing was held on 4/26 for SB 56.
Two separate legislative proposals are pending to allow qualified patients to obtain and legally consume marijuana.

The preferable of the two bills, Senate Bill 56, permits the state’s Department of Health and Senior Services (DHSS) to “grant licenses for the cultivation, manufacture, distribution, and sale of marijuana for medical use.” Importantly, it authorizes qualified patients and caregivers the opportunity to cultivate their own cannabis at home. This option ensures that patients will have an uninterrupted supply of medical cannabis if there is a delay in the establishment of state licensed dispensaries or if they do not reside near such a facility. 

Separate legislation, Senate Bill 153, is also pending. However, this legislation significantly limits patients’ options to self-medicate in the manner that they believe is best. For example, it does not allow patients to cultivate their own supply of medicine, and it also places potential restrictions on how patients may consume their medicine. 

Twenty-nine states and the District of Columbia have enacted statewide provisions allowing patients access to cannabis therapy. Missouri patients deserve these same protections.

Statewide polling data compiled in 2016 determined that 62 percent of voters support regulating medical marijuana access. In September, Secretary of State Jason Kander called on lawmakers to move swiftly to legalize medical cannabis, stating, “The Missouri General Assembly should pass legislation to allow medical marijuana so Missouri families that could greatly benefit from it don’t have to watch their loved ones continue suffering.” If lawmakers fail to act this year, advocates are anticipated to place the measure on the 2018 ballot.

Please enter your zip code below to contact your state elected officials and urge them to support Senate Bill 56. For more information please visit Missouri NORML’s page.

Update: SB 212 and HB 3521 failed to receive action before the legislative crossover dates, and are dead for this legislative session.
Update: Members of the House subcommittee on Medical, Military, Public and Municipal Affairs voted 3-0 on February 21 to report HB 3521 for consideration before the full Committee
Update: Testimony was taken on S. 212 before the Senate Medical Affairs subcommittee on February 16. Among those testifying in favor of the bill included former US Attorney for the District of South Carolina Bill Nettles. 
Update: The Charleston Post and Courier has endorsed the S.C. Compassionate Care Act.
Update: South Carolina Gov. Henry McMasters says he opposes legalizing marijuana, calling it a “bad idea.”
Legislation is pending, Senate Bill 212 and House Bill 3521, to establish a program to provide qualified patients with legal access to medical marijuana products.

Under this program, patients would be permitted to obtain up to two ounces of cannabis and/or cannabis-infused products, such as extracts or edibles, from a state-licensed dispensing facility. 

Patients must be diagnosed with one of the following debilitating conditions to qualify for access: “cancer, glaucoma, positive status for human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis C, amyotrophic lateral sclerosis, Crohn’s disease, ulcerative colitis, agitation of Alzheimer’s disease, post-traumatic stress disorder (PTSD), autism, idiopathic pulmonary fibrosis, Parkinson’s disease, neural-tube defects, or the treatment of these conditions; or a chronic or debilitating disease or medical condition or its treatment that produces one or more of the following: cachexia or wasting syndrome; severe, debilitating pain; severe nausea; seizures; neurological disorders; or severe and persistent muscle spasms including, but not limited to, those characteristic of multiple sclerosis.” The measure also restricts patients from smoking cannabis, but does not prohibit vaporization. 

While NORML believes that such restrictions on smoking are unnecessary, we also are doubtful that such prohibitions can feasibly be enforced. Further, this legislation is more expansive than the state’s existing CBD-specific law, which only applies to patients with intractable epilepsy and has failed to provide needed relief to the patient community. Ultimately, we would like to see this measure amended to include patients’ right to home grow.

The Senate bill appears to have broad legislative support. According to this news story, correspondents were unable to find any lawmakers to go on record in opposition to the bill.

A separate, broader measure is pending in the House. House Bill 3128, the Put Patients First Act, permits qualified patients to engage in cannabis therapy and to obtain cannabis from state-licensed dispensaries. Under this act, qualifying patients may possess “up to two ounces of a usable form of marijuana.” They also have the option of cultivating their own cannabis at home.

A second, more narrow bill, House Bill 3162, seeks to provide medical marijuana access for certain military veterans. It allows those who were discharged in honorable fashion and later diagnosed with PTSD “to possess twenty-eight grams or one ounce or less of marijuana or ten grams or less of hashish.”

Twenty-nine states and the District of Columbia have enacted statewide provisions allowing patients access to cannabis therapy. South Carolina patients deserve these same protections.

Please enter your information below to contact your state elected officials and urge them to support medical marijuana access in South Carolina.

Update: On Tuesday, February 28, a special committee — the 17-member Committee on Marijuana Legalization Implementation — charged with facilitating Maine’s transition into a legal marijuana marketplace will hold a meeting to hear public comments on the process as well as to review the dozens of marijuana-related bills pending in the Legislature.
Governor Paul LePage recently suggested abolishing Maine’s medical marijuana program – a program that was approved by a majority of voters on two separate occasions.

In a December 15 radio interview, Gov. LePage said that he sees “no need” to continue to implement a separate medical cannabis program in Maine when adult use becomes legally regulated. “Why do we need medical marijuana?” he asked. “We’ve got to get rid of medical marijuana.”

Tell the Governor ‘no.’

Tens of thousands of Mainers have grown to rely on this program for safe, above ground access to a substance that provides them with symptomatic relief. It is unfair to ask them to switch from their trusted providers to new retailers who may have little or no experience providing for patients’ needs.

Further, many of these patient populations use cannabis to treat chronic conditions, whereas adult non-patient users may only consume cannabis intermittently. It is inappropriate to subject these patients to the litany of taxes associated with retail cannabis. Other medicines are not subject to such taxes and those patients explicitly using cannabis as a medicine should not be forced to pay inflated retail prices.

Finally, many patients utilize niche products, such as marijuana-infused salves and tinctures high in cannabinoids other than THC – the primary mood-altering component in cannabis. It is questionable whether retailers catering to the adult use market will continue to produce or provide these specialized products and formulations, potentially leaving patients out in the cold.

Ultimately, patients’ motivations for accessing cannabis and the type of cannabis they seek to obtain are very different than that of non-patients. As a result, NORML urges Governor LePage to keep the existing medical marijuana program in place while simultaneously working to implement the state’s new adult use regulations swiftly and in accordance with the will of the majority of Maine voters.  

After the 2016 Presidential campaign dust has settled, Michigan NORML had a distrubing thought: with their states electoral votes as well as the White House going to Donald Trump and Governor Mike Pence, what will happen to the good people in Michigan who are being helped by the state’s medical marijuana program? Futhermore, how will cannabis policy change under the new administration at the federal level?
In that spirit, Michigan NORML crafted the letter below to send to Vice President-Elect Mike Pence in the hopes of gaining clarity and has recruited over 50 other NORML chapters from across the country to sign-on. 
Add your name to join NORML’s national network in keeping up the pressure to bring an end to the war on responsible marijuana users. 

Update: The Texas House of Representatives Calendar Committee refused to schedule a vote for HR 2107 and it will not recieve any futher consideration this session. Watch the video from the bills sponsors, State Representatives Eddie Lucio III and Jason Issac.

Update: The Texas House of Representatives Committee on Public Health approved HR 2107 on May 5 by a vote of 7-2. The bill will now be considered by the Calendars Committee to determine the date of the full House vote. 
Update: HB 2107 had a hearing on May 2 and after powerful targeted testimony, the number of cosponsors for the bill jumped from 5 to 75!
Update: A bipartisan House version of SB269 to legalize medical marijuana in the state of Texas has just been introduced by Representative Eddie Lucio III, D-Brownsville, titled HB 2107,
State Senator Jose Menendez has filed Senate Bill 269, currently making its way through committee, to protect qualified patients who consume cannabis and to provide for the state-licensed production and distribution of the plant.
SB 269 authorizes the possession, production, and distribution of medical marijuana and marijuana-infused products to qualified patients. Patients would receive cannabis through a network of private dispensaries and operators, similar to pharmacies, regulated under “strict guidelines” by the Texas Department of Public Safety. The state would use existing infrastructure and build upon the registry already established under the Compassionate Use Act, or SB 339, a 2015 bill Sen. Menendez co-authored and helped pass that lets patients with intractable epilepsy receive low-THC cannabis oil.
 
Thirty states and the District of Columbia have passed laws allowing patients access to cannabis therapy. Texas patients deserve these same protections.
 
Please enter your info below to contact your state elected officials and urge them to support this pending legislation. For more information please visit Texas NORML’s website or find your regional chapter here.